Trials / Completed
CompletedNCT03628703
Response Inhibition in Tourette Syndrome
Using Repetitive Transcranial Magnetic Stimulation to Modulate Response Inhibition in Tourette Syndrome
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 10 (actual)
- Sponsor
- Children's Hospital Medical Center, Cincinnati · Academic / Other
- Sex
- All
- Age
- 10 Years – 17 Years
- Healthy volunteers
- Not accepted
Summary
Tics are the hallmark symptoms in Tourette Syndrome. Patients with Tourette Syndrome have difficulties controlling unwanted movements. The ability to control the motor system involves the pre-supplementary motor area (pre-SMA) in the brain. In this study, we will use Transcranial Magnetic Stimulation to modulate the pre-SMA and determine effect on the ability to stop an unwanted action in a behavior task (stop signal task).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Repetitive TMS | Repetitive Intermittent Theta-Burst Transcranial Magnetic Stimulation over the right Pre-supplementary Motor Area |
Timeline
- Start date
- 2019-04-22
- Primary completion
- 2023-06-30
- Completion
- 2024-03-15
- First posted
- 2018-08-14
- Last updated
- 2024-04-18
- Results posted
- 2024-04-18
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT03628703. Inclusion in this directory is not an endorsement.